27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Since late 2019, space- and satellite-based companies and other companies in the aerospace and defen...
Read More >
After an initial delay, payroll and wage withholdings to fund the Massachusetts paid family and medi...
Read More >
We recently provided an update on the status of higher-education and social-infrastructure projects ...
Read More >
Employees who transition genders may ask their employer and co-workers to begin addressing them with...
Read More >
Last Friday, I had the opportunity to talk about Artificial Intelligence in the Workplace at the CBI...
Read More >
Draft German investment control rules give the German government broader powers to intervene against...
Read More >